Could your own fat cells heal Crohn's fistulas? new trial tests it
NCT ID NCT04612465
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tests whether injecting a patient's own fat-derived stem cells, along with a glue, can close fistulas caused by Crohn's disease. 46 adults with Crohn's and at least one fistula are taking part. The main goal is to see if the fistula closes completely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Autologous adipose-derived stem cells (a patient's own fat stem cells) combined with fibrin glue
What this could lead to
If it works, this could offer a new way to close hard-to-treat fistulas in Crohn's disease, potentially reducing the need for surgery or long-term medication.
What could go wrong
This is a small Phase 3 trial with only 46 people, so results may not apply to everyone. Stem cell treatments can have side effects like infection or inflammation, and the fistula might not fully close.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, Seoul, 05505, South Korea
-
Samsung Medical Center
Seoul, Seoul, 06351, South Korea
-
Seoul Natinoal Univetsity Hospital
Seoul, Seoul, 03080, South Korea
-
Severance
Seoul, Seodaemun-gu, 03722, South Korea